High expression of PODXL, in particular in the membrane of tumour cells, has previously been demonstrated to correlate to an impaired prognosis in many major cancer forms like breast cancer [9], colorectal cancer [10–12], ovarian cancer [13], glioblastoma [14] and urothelial bladder cancer [15]. Here, PODXL is linked to bladder transitional cell carcinoma.